*ENLIVEN THERAPEUTICS Q4 OPERATING EXPENSES USD 26.896 MILLION
*ENLIVEN THERAPEUTICS Q4 NET INCOME USD -23.18 MILLION
*ENLIVEN THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -26.896 MILLION
*ENLIVEN THERAPEUTICS Q4 BASIC EPS USD -0.46
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 13-MAR-202520:05:02.533 GMT